GOLGA3: A Potential Drug Target and Biomarker (G2802)

Target Name: GOLGA3

NCBI ID: G2802

GOLGA3: A Potential Drug Target and Biomarker

Golgi articles

Golgi are a type of intracellular organelle that play a crucial role in the delivery and processing of proteins. They are composed of a network of filaments and vesicles that expand and constrict to remove and transport various proteins to and from the cell surface. Golgi dysfunction has been implicated in a wide range of diseases, including neurodegenerative disorders, cancer, and autoimmune diseases.

GOLGA3, also known as Golgin A3, is a protein that is expressed in the Golgi. It is a 21-kDa glycoprotein that contains a unique N-terminal region that is involved in its stability and localization to the Golgi membrane. GOLGA3 has also been shown to play a role in the delivery of various proteins to the cell surface, including proteins involved in cell signaling and inflammation.

Drug targets

GOLGA3 has been identified as a potential drug target due to its unique structure and its involvement in various cellular processes. One of the main reasons for its potential as a drug target is its involvement in the delivery of proteins to the cell surface, which makes it a target for drugs that can modulate the delivery and processing of proteins.

GOLGA3 has been shown to interact with various drug molecules, including small molecules, peptides, and proteins. For example, studies have shown that GOLGA3 can interact with inhibitors of the protein kinase B, which is involved in cell signaling. Additionally, GOLGA3 has been shown to interact with various proteins involved in the delivery of proteins to the cell surface, including the transmembrane protein known as T-cell antigen 4 (TAG-4).

GOLGA3 has also been shown to play a role in the regulation of cellular processes that are important for the development and progression of cancer. For example, studies have shown that GOLGA3 can be involved in the regulation of cell cycle progression, which is important for the development of cancer cells that have an increased ability to divide and proliferate.

Biomarkers

GOLGA3 has also been shown to be involved in the regulation of cellular processes that are important for the diagnosis and prognosis of various diseases. For example, studies have shown that GOLGA3 can be involved in the regulation of inflammation, which is important for the development and progression of inflammatory diseases such as cancer and neurodegenerative disorders.

In addition, GOLGA3 has also been shown to play a role in the regulation of cellular processes that are important for the development and progression of autoimmune diseases. For example, studies have shown that GOLGA3 can be involved in the regulation of the immune response, which is important for the development and progression of autoimmune diseases such as rheumatoid arthritis and multiple sclerosis.

Conclusion

GOLGA3 is a protein that has been shown to play a role in various cellular processes that are important for the development and progression of diseases. Its unique structure and its involvement in the delivery and processing of proteins make it a potential drug target. Additionally, GOLGA3 has also been shown to play a role in the regulation of various cellular processes that are important for the diagnosis and prognosis of diseases. Further research is needed to fully understand the role of GOLGA3 in cellular processes and its potential as a drug target and biomarker.

Protein Name: Golgin A3

Functions: Golgi auto-antigen; probably involved in maintaining Golgi structure

More Common Targets